, Tracking Stock Market Picks
Enter Symbol:

Mkt Outperform
up 0.82 %

MEDASSETS INC. (mdas) rated Mkt Outperform with price target $25 by Avondale

Posted on: Wednesday,  Apr 7, 2010  1:25 PM ET by Avondale

Avondale rated Mkt Outperform MEDASSETS INC. (NASDAQ: MDAS) on 04/07/2010, when the stock price was $20.49. Since
then, MEDASSETS INC. has gained 0.83% as of 12/29/2015's recent price of $20.66.
If you would have followed this Avondale's recommendation on MDAS, you would have gained 0.82% of your investment in 2092 days.

MedAssets, Inc. provides technology-enabled products and services, which together deliver solutions designed to improve operating margin and cash flow for hospitals and health systems. These solutions are offered primarily through Company-hosted software, or software as a service (SaaS), supported by enterprise-wide sales, account management, implementation services and consulting. The Company delivers its solutions through two business segments: Revenue Cycle Management, which provides a suite of products and services that span what has traditionally been viewed as the hospital revenue cycle, and Spend Management, which helps customers manage their non-labor expense categories through a combination of group purchasing, performance improvement consulting, including implantable physician preference items (PPI), cost and utilization management and service line consulting, and business intelligence tools. On June 2, 2008, the Company acquired Accuro Healthcare Solutions, Inc.

Avondale’s research analysts are charged with producing high quality, independent, value-added, and timely investment analysis / advice. The firm’s strategy is to deemphasize maintenance research, and instead direct the overwhelming majority of our efforts on developing well-constructed, actionable recommendations, in part by leveraging proprietary networks of industry contacts. Avondale’s growing research department now totals 25 professionals. Senior analysts average 14 years of industry experience and are routinely recognized by a variety of nationally known rating entities. In the last two years, Avondale Analysts were named to the Wall Street Journal’s Best on the Street poll as well as’s Top Analyst Rankings.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/7/2010 1:25 PM Buy
20.49 25.00
as of 12/31/2010
1 Week down  -1.92 %
1 Month up  7.16 %
3 Months down  -5.51 %
1 YTD down  -2.97 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy